Year: 2016
Type: article
Abstract: Alcoholic hepatitis (AH) is the most severe form of alcoholic liver disease for which there are no effective therapies. Patients with AH show impaired hepatocyte proliferation, expansion of inefficient ductular cells and high lipopolysaccharide (LPS) levels. It is unknown whether LPS mediates ductular cell expansion. We performed transcriptome studies and identified keratin 23 (KRT23) as a new ductular cell marker. KRT23 expression correlated with mortality and LPS serum levels. LPS-TLR4 pathway role in ductular cell expansion was assessed in human and mouse progenitor cells, liver slices and liver injured TLR4 KO mice. In AH patients, ductular cell expansion correlated with portal hypertension and collagen expression. Functional studies in ductular cells showed that KRT23 regulates collagen expression. These results support a role for LPS-TLR4 pathway in promoting ductular reaction in AH. Maneuvers aimed at decreasing LPS serum levels in AH patients could have beneficial effects by preventing ductular reaction development.
Source: Scientific Reports
DOI: 10.1038/srep35610
Authors: Gemma Odena, Jiegen Chen, Juan Jose Lozano, Jose Altamirano, Daniel Rodrigo-Torres, Silvia Affo, Oriol Morales-Ibanez, Hiroshi Matsushita, Jian Zou, Raluca Dumitru, Juan Caballeria, Pere Gines, Vicente Arroyo, Min You, Pierre-Emmanuel Rautou, Dominique Valla, Fulton Crews, Ekihiro Seki, Pau Sancho-Bru, Ramon Bataller
Institutions: University of North Carolina at Chapel Hill, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Consorci Institut D'Investigacions Biomediques August Pi I Sunyer, Cedars-Sinai Medical Center, Hospital Clínic de Barcelona, Northeast Ohio Medical University, Inserm, Hôpital Beaujon, Sorbonne Paris Cité, Assistance Publique – Hôpitaux de Paris, Paris Cardiovascular Research Center, Université Paris Diderot, Université Paris Descartes
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,690
Funders: Generalitat de Catalunya, Banco Bilbao Vizcaya Argentaria, Instituto de Salud Carlos III, National Institute on Alcohol Abuse and Alcoholism, National Institute of Diabetes and Digestive and Kidney Diseases, Center for Gastrointestinal Biology and Disease, School of Medicine, University of North Carolina at Chapel Hill
Awards: Molecular Subtypes for Targeted Therapies in Alcoholic Hepatitis, MIF in progression and treatment of ALD, Ethanol Regulation of Adiponectin and its Signaling, Effect of Ethanol on Lipid Metabolism, Synergistic Actions By Multiple Toll-Like Receptors in Alcoholic Liver Disease, G7496311294, Extracellular Matrix Regulates Hepatic Stellate Cell Activation and Fibrosis
OpenAlex ID: W2534149233
